Similar Papers

Paper Title
Journal
Date
Author
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
T Powles ... G De Velasco
Annals of Oncology | VOL. 32
T Powles, et. al.T Powles ... G De Velasco
28 Sep 2021
Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences
Oscar C.Y Yang ... Patrick J Pollard
Kidney International | VOL. 84
Oscar C.Y Yang, et. al.Oscar C.Y Yang ... Patrick J Pollard
01 Oct 2013
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Escudier ... A Horwich
Annals of Oncology | VOL. 25
B Escudier, et. al.B Escudier ... A Horwich
01 Sep 2014
Chronic Kidney Disease in Patients With Renal Cell Carcinoma
Anthony Chang ... Mitchell Rosner
Advances in Chronic Kidney Disease | VOL. 21
Anthony Chang, et. al.Anthony Chang ... Mitchell Rosner
20 Dec 2013
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors
J.M Riedl ... R.B Corcoran
Annals of Oncology | VOL. -
J.M Riedl, et. al.J.M Riedl ... R.B Corcoran
01 Feb 2025
Whole genome sequencing powered ctDNA sequencing for breast cancer detection
I Garcia-Murillas ... N.C Turner
Annals of Oncology | VOL. -
I Garcia-Murillas, et. al.I Garcia-Murillas ... N.C Turner
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.